Logo image of SIEN

SIENTRA INC (SIEN) Stock Price, Forecast & Analysis

USA - NASDAQ:SIEN - US82621J2042 - Common Stock

0.174 USD
-0.04 (-18.69%)
Last: 2/21/2024, 8:07:31 PM
0.1798 USD
+0.01 (+3.33%)
After Hours: 2/21/2024, 8:07:31 PM

SIEN Key Statistics, Chart & Performance

Key Statistics
Market Cap2.08M
Revenue(TTM)90.30M
Net Income(TTM)-59120000
Shares11.96M
Float10.81M
52 Week High4.94
52 Week Low0.16
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-5.57
PEN/A
Fwd PEN/A
Earnings (Next)03-12 2024-03-12/amc
IPO2014-10-29
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies


SIEN short term performance overview.The bars show the price performance of SIEN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

SIEN long term performance overview.The bars show the price performance of SIEN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SIEN is 0.174 USD. In the past month the price decreased by -69.47%. In the past year, price decreased by -89.45%.

SIENTRA INC / SIEN Daily stock chart

SIEN Latest News, Press Relases and Analysis

SIEN Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ALC ALCON INC 24.59 37.11B
COO COOPER COS INC/THE 17.16 13.72B
SOLV SOLVENTUM CORP 10.9 11.49B
ALGN ALIGN TECHNOLOGY INC 13.83 9.69B
BLCO BAUSCH + LOMB CORP 36.12 5.50B
MMSI MERIT MEDICAL SYSTEMS INC 23.26 5.12B
LNTH LANTHEUS HOLDINGS INC 8.4 3.65B
ICUI ICU MEDICAL INC 17.24 3.20B
XRAY DENTSPLY SIRONA INC 6.44 2.20B
HAE HAEMONETICS CORP/MASS 14.43 3.23B
UFPT UFP TECHNOLOGIES INC 25 1.72B
ESTA ESTABLISHMENT LABS HOLDINGS N/A 1.88B

About SIEN

Company Profile

SIEN logo image Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Irvine, California and currently employs 304 full-time employees. The company went IPO on 2014-10-29. The firm is engaged in transformative treatments and technologies focused on advancing plastic surgery. The firm provides medical aesthetics products to certified plastic surgeons and patients. The company has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The firm sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.

Company Info

SIENTRA INC

3333 Michaelson Dr, Suite 650

Irvine CALIFORNIA 93117 US

CEO: Ronald Menezes

Employees: 304

SIEN Company Website

Phone: 18055623500

SIENTRA INC / SIEN FAQ

Can you describe the business of SIENTRA INC?

Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Irvine, California and currently employs 304 full-time employees. The company went IPO on 2014-10-29. The firm is engaged in transformative treatments and technologies focused on advancing plastic surgery. The firm provides medical aesthetics products to certified plastic surgeons and patients. The company has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The firm sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.


Can you provide the latest stock price for SIENTRA INC?

The current stock price of SIEN is 0.174 USD. The price decreased by -18.69% in the last trading session.


What is the dividend status of SIENTRA INC?

SIEN does not pay a dividend.


How is the ChartMill rating for SIENTRA INC?

SIEN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


How is the valuation of SIENTRA INC (SIEN) based on its PE ratio?

SIENTRA INC (SIEN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.57).


What is SIENTRA INC worth?

SIENTRA INC (SIEN) has a market capitalization of 2.08M USD. This makes SIEN a Nano Cap stock.


SIEN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SIEN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to SIEN. Both the profitability and financial health of SIEN have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SIEN Financial Highlights

Over the last trailing twelve months SIEN reported a non-GAAP Earnings per Share(EPS) of -5.57. The EPS increased by 48.9% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -42.26%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%45.42%
Sales Q2Q%-13.42%
EPS 1Y (TTM)48.9%
Revenue 1Y (TTM)2.46%

SIEN Forecast & Estimates

9 analysts have analysed SIEN and the average price target is 2.04 USD. This implies a price increase of 1072.41% is expected in the next year compared to the current price of 0.174.

For the next year, analysts expect an EPS growth of 61.42% and a revenue growth -3.12% for SIEN


Analysts
Analysts82.22
Price Target2.04 (1072.41%)
EPS Next Y61.42%
Revenue Next Year-3.12%

SIEN Ownership

Ownership
Inst OwnersN/A
Ins Owners40.75%
Short Float %N/A
Short RatioN/A